Your browser doesn't support javascript.
loading
Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
The Korean Journal of Internal Medicine ; : 1188-1196, 2019.
Artigo em Inglês | WPRIM | ID: wpr-919128
ABSTRACT
The incidence of colorectal cancer (CRC) has increased. CRC is the third most common cancer and the fourth most common cause of cancer-related deaths in Korea. Palliative chemotherapy can be used to shrink tumors and ease symptoms caused by the cancer when cure is not possible. It is important to identify chemotherapeutic agents that can be used to effectively treat metastatic CRC (mCRC) and thus improve the survival and quality of life of patients with mCRC. This review aimed to evaluate the recent developments in palliative chemotherapy for mCRC and the biological or targeted agents used based on genetic alterations.
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Inglês Revista: The Korean Journal of Internal Medicine Ano de publicação: 2019 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Inglês Revista: The Korean Journal of Internal Medicine Ano de publicação: 2019 Tipo de documento: Artigo